PERCUTANEOUS ETHANOL INJECTION THERAPY OF HEPATOMA

被引：64

作者：

LIVRAGHI, T

VETTORI, C

机构：

[1] Reparto di Radiologia, Ospedale Civile, Vimercate, Milano, 20059, Via C. Battisti

来源：

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY | 1990年 / 13卷 / 03期

关键词：

Alcohol infusion; Hepatocellular carcinoma; Liver neoplasms; Liver; interventional procedures;

D O I：

10.1007/BF02575466

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Percutaneous ethanol injection (PEI) under ultrasound guidance is a new therapeutic possibility for patients with small hepatocellular carcinoma (HCC). In our series, 35 patients with a total of 50 tumors were treated (tumor size 0.8-5.0 cm). No significant complications occurred after 502 sessions of ethanol injection. Thirty patients presented complete remission, as no evidence of residual HCC was revealed during the follow-up (mean 16 months). Five patients with lesions larger than 3.5 cm presented only partial remission. The survival curves at 1, 2, and 3 years (Kaplan Meier method) were 100%, 100%, and 80%, respectively. In comparison with the survival curves of untreated and surgically treated patients. PEI seems to be the better treatment for operable HCC smaller than 3 cm, and for lesions smaller than 5 cm in patients with high surgical risk. © 1990 Springer-Verlag New York Inc.

引用

页码：146 / 152

页数：7

共 29 条

[1]

Oka H., Kurioka N., Shitani M., Ohtake K., Ikeoka N., Asai H., Early detection of hepatocellular carcinoma in a prospective study of 160 patients with cirrhosis of the liver, J Ultrasound Med, 7, (1988)

[2]

Okuda K., Primary liver cancer. Quadrennial review lecture, Dig Dis Sci, 31, pp. 1335-1465, (1986)

[3]

Cottone M., Turri M., Caltagirone M., Maringhini A., Sciarrino E., Virdone R., Fusco G., Orlando A., Marino L., Pagliaro L., Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: A prospective study, Hepato-Gastroenter, 35, pp. 101-103, (1988)

[4]

Naccarato R., Farinati F., Zagolin M., Early diagnosis of hepatocellular carcinoma: Can we modify the natural history of the disease?, New radiologic imaging and intervention in general surgery, pp. 39-42, (1989)

[5]

Gozzetti G., Mazziotti A., Cavallari A., Bellusci R., Bolondi L., Grigioni W., Bragagua R., Grazi G.L., De Raffaele E., Clinical experience with hepatic resections for hepatocellular carcinoma in patients with cirrhosis, Surgery, 166, pp. 503-510, (1988)

[6]

Kinami Y., Shigeki T., Miyazaki I., Hepatic resection for hepatocellular carcinoma associated with liver cirrhosis, World J Surg, 10, pp. 294-301, (1986)

[7]

Lee C.S., Sung J.L., Hwang L.Y., Sheu J.C., Chen D.S., Lin T.Y., Beasley R.P., Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma, Surgery, 99, pp. 481-490, (1986)

[8]

Nagao T., Goto S., Kawamo N., Inoue S., Mizuta T., Omori Y., Morioka Y., Hepatic resection for hepatocellular carcinoma, Ann Surg, 205, pp. 33-40, (1987)

[9]

Nagasue N., Yukaya N., Okawa Y., Sasaki Y., Chang Y., Niimi K., Clinical experience with 118 hepatic resections for hepatocellular carcinoma, Surgery, 99, pp. 694-701, (1986)

[10]

Okamoto E., Yamamaka N., Toyosaka A., Tamaka N., Yabuki K., Current status of hepatic resection in the treatment of hepatocellular carcinoma, Neoplasm of the liver, pp. 353-366, (1987)

← 1 2 3 →